<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cytokines controlling the development of human interleukin (IL) 17--producing T helper cells in vitro have been difficult to identify </plain></SENT>
<SENT sid="1" pm="."><plain>We addressed the question of the development of human IL-17--producing T helper cells in vivo by quantifying the production and secretion of IL-17 by fresh T cells ex vivo, and by T cell blasts expanded in vitro from patients with particular genetic traits affecting transforming growth factor (TGF) beta, IL-1, IL-6, or IL-23 responses </plain></SENT>
<SENT sid="2" pm="."><plain>Activating mutations in TGFB1, TGFBR1, and TGFBR2 (Camurati-Engelmann disease and Marfan-like syndromes) and loss-of-function mutations in IRAK4 and MYD88 (Mendelian predisposition to pyogenic <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>) had no detectable impact </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, dominant-negative mutations in STAT3 (<z:hpo ids='HP_0000006'>autosomal-dominant</z:hpo> <z:e sem="disease" ids="C0022398" disease_type="Disease or Syndrome" abbrv="HIES">hyperimmunoglobulin E syndrome</z:e>) and, to a lesser extent, null mutations in IL12B and IL12RB1 (Mendelian susceptibility to <z:e sem="disease" ids="C0026918" disease_type="Disease or Syndrome" abbrv="">mycobacterial diseases</z:e>) impaired the development of IL-17--producing T cells </plain></SENT>
<SENT sid="4" pm="."><plain>These data suggest that IL-12Rbeta1- and STAT-3--dependent signals play a key role in the differentiation and/or expansion of human IL-17-producing T cell populations in vivo </plain></SENT>
</text></document>